BN Business News
Ajouter votre entreprise →
Cette traduction est en cours de préparation. En attendant, nous affichons temporairement la version originale en anglais.

Énergie et environnement · 28/02/20052 min de lecture

Advisory Committee on the Medical Uses of Isotopes: Meeting Notice

Traduction automatique locale · Langue originale de la source

Résumé

The U.S. Nuclear Regulatory Commission will convene a meeting of the Advisory Committee on the Medical Uses of Isotopes (ACMUI) on April 20 and 21, 2005. A sample of agenda items to be discussed during the public sessions includes: (1) Status of Rulemaking: Pt. 35 Training and Experience; (2) Status and Update: Redefining Medical Events; (3) Case Experience in Using I-125 Seeds as Markers; (4) FDA Radiation Dose Limits for Human Research Subjects Using Certain Radiolabeled Drugs, and (5) Establishing Guidance on Exceeding Dose Limits for Members of the Public who would serve as Caregivers to Persons undergoing Radiopharmaceutical Therapy. To review the agenda, see http:// www.nrc.gov/reading-rm/doc-collections/acmui/agenda/ or contact [email protected]. Furthermore, the ACMUI will brief the Commission regarding its activities, on April 20, 2005. Purpose: Discuss issues related to 10 CFR 35, Medical Use of Byproduct Material. Dates and Times for Public Meetings: April 20, 2005, from 8 a.m. to 5 p.m.; and April 21, 2005, from 10 a.m. to 5 p.m. Address for Public Meetings: Bethesda North Marriott Hotel & Conference Center, 5701 Marinelli Road, North Bethesda, MD 20852. The precise room numb

Langue originale de la source: Federal Register — Nuclear Regulatory CommissionOuvrir le communiqué original →

Explorer les analyses

Analyses business →